New Choice In Adult Dairy Cow Worming

UK - The moxidectin wormer CYDECTIN Cattle Pour On has been authorised for use in adult dairy cows, bringing competition and choice to a sector in which there was previously only one licensed treatment.
calendar icon 28 September 2011
clock icon 2 minute read
Pfizer Animal Health

With persistency against re-infection by stomach worms (Ostertagia) and lungworm (Dictyocaulus) of five and six weeks respectively from a single dose, CYDECTIN is the longest available treatment against the main worm species that affect dairy cow performance.

It is recommended that, with any authorised anthelmintic, the optimum time to treat dairy cows is in the late dry period, according to Pfizer vet Andrew Montgomery. “This is because during early lactation, cows will gain most from increased feed intake that can result from deworming, which can bring benefits throughout their lactation,” he says.

Licensed for use in dairy cows, with a short six-day milk withhold, the moxidectin treatment is recommended to be used as part of the management routine for pre-calving cows, for example when moved into the close to calving or transition cow group, a few weeks pre-calving. Used in this way, there is no loss of milk from the withdrawal time and the response to treatment is maximised.


CYDECTIN® Cattle Pour On

In support of the product, Pfizer can provide a free bulk milk test to assess worm challenge, which can also help predict the likely milk production response to treatment. This is available via VPS animal medicine suppliers, supported by nine Pfizer VPS regional vets.

Dosage is one ml per 10kg bodyweight, which is consistent with other products for worming dairy cows. However, Pfizer suggest the cost is likely to be significantly lower due to the introduction of competition and choice to this dairy sector. The company is encouraging farmers to ask their animal health supplier for a comparative quote for worming dairy cows.

TheCattleSite Newsdesk

© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.